Thus, we investigated the oncogenic role of SNHG3 in CRC by conducting in vitro and in vivo experiments and revealed that exosomal SNHG3 can promote the migration of CRC through upregulating β-catenin and activating the EMT pathway. Here, SNHG3 is linked to colorectal carcinoma.